Lv1
18 积分 2022-02-09 加入
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
1天前
已完结
Long-Term Efficacy and Safety of Denosumab: Insights beyond 10 Years of Use
20天前
已完结
Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures
20天前
已完结
A systematic literature review of Janus kinase inhibitors for the treatment of systemic sclerosis
6个月前
已完结
Use of the oral JAK inhibitor Tofacitinib in the treatment of morphea: A retrospective study
6个月前
已关闭
Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease
6个月前
已完结
Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease
7个月前
已完结
Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality
7个月前
已完结
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
7个月前
已完结
皖公网安备34019202002308
